472
Participants
Start Date
December 31, 2004
Primary Completion Date
April 30, 2006
Study Completion Date
April 30, 2006
Tiotropium inhalation capsules
Placebo inhalation capsules
A.Z. VUB, Brussels
St. Elisabethziekenhuis, Herentals
Sint-Elisabethziekenhuis, Turnhout
H:S Bispebjerg Hospital, K?benhavn NV
Lungemedicinsk afdeling Y, Hellerup
Medicinsk afdeling B0642, Hiller?d
Boehringer Ingelheim Investigational Site, Hasselt
Boehringer Ingelheim Investigational Site, Genk
Boehringer Ingelheim Investigational Site, Durban
CHU Sart Tilman, Angleur
Clinique Reine Astrid, Malmedy
Lungemedicinsk Forskning, Odense C
Boehringer Ingelheim Investigational Site, George
Boehringer Ingelheim Investigational Site, Somerset West
Boehringer Ingelheim Investigational Site, Bellville
Boehringer Ingelheim Investigational Site, Paarl
Boehringer Ingelheim Investigational Site, Cape Town
Boehringer Ingelheim Investigational Site, Cape Town
Boehringer Ingelheim Investigational Site, Berlin
Boehringer Ingelheim Investigational Site, Berlin
Hopital Ambroise Pare, Marseille
MEDARS GmbH, Berlin
Boehringer Ingelheim Investigational Site, Rudersdorf
A.O. S. Martino e Cliniche Universitarie di Genova, Genova
Universita di Genova, Genova
Pneumologisches Forschungsinstitut GmbH am Krankenhaus, Hamburg
Boehringer Ingelheim Investigational Site, Minden
Boehringer Ingelheim Investigational Site, Montpellier
Hopital Arnaud de Villeneuve, Montpellier
Boehringer Ingelheim Investigational Site, Nantes
Centre Medical Erdre St Augustin, Nantes
A. O. Universitaria di Ferrara - Arcispedale S. Anna, Ferrara
Med. Einrichtung der Universitat zu Koln, Cologne
Hopital Maison blanche, Reims
Boehringer Ingelheim Investigational Site, Bonn
A.O. Pisana, Pisa
Hopital Notre Dame de Bon Secours, Metz
Boehringer Ingelheim Investigational Site, Frankfurt am Main
Hopital Gabriel Montpied, Clermont-Ferrand
Boehringer Ingelheim Investigational Site, Gelnhausen
Boehringer Ingelheim Investigational Site, Chamalières
Hopital d'Annecy, Annecy
Boehringer Ingelheim Investigational Site, München
Inamed Research GmbH & Co. KG, Gauting
Boehringer Ingelheim Investigational Site, Fürth
Hopital Prive Antony, Antony
VGH Research Pavillion, Vancouver
BG 034, Room C2027, Winnipeg
Department of Medicine, Health Sciences Centre, Hamilton
Boehringer Ingelheim Investigational Site, Mississauga
Boehringer Ingelheim Investigational Site, Toronto
Respiratory Research Lab, Toronto
Boehringer Ingelheim Investigational Site, Toronto
Department of Respiratory Medicine, Toronto
Centre de Recherche Clinique -CUSE, Sherbrooke
Hopital Laval, Ste-Foy
Lungemedicinsk Forskning 2B, Aarhus
Lungemedicinsk Klinik, Hvidovre
Boehringer Ingelheim Investigational Site, Nice
ClinPharm Internat. GmbH & Co. KG, Görlitz
Ziekenhuisgroep Twent, Almelo
Amphia ziekenhuis, Breda
Atrium medisch centrum, Heerlen
Ziekenhuigroep Twente, Hengelo
Medisch Centrum Leeuwarden, Leeuwarden
Antonius Ziekenhuis, Sneek
Maxima Medisch Centrum, Velthoven
Boehringer Ingelheim Investigational Site, Pretoria
Lead Sponsor
Boehringer Ingelheim
INDUSTRY